PDF herunterladen
CC BY-NC-ND 4.0 · Thromb Haemost 2019; 119(03): 421-430
DOI: 10.1055/s-0038-1676987
Blood Cells, Inflammation and Infection
Georg Thieme Verlag KG Stuttgart · New York

Deep Vein Thrombosis is Modulated by Inflammation Regulated via Sirtuin 1/NF-κB Signalling Pathway in a Rat Model

Xiaolan Yao
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Wenpei Chen
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Jin Liu
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Han Liu
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Janis Y. Zhan
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Shixia Guan
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Ziqi Lu
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Ping Tang
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Peng Li
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
,
Baoqin Lin
1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
› Institutsangaben Funding This work was supported by Guangdong Public Welfare Research and Capacity Building Projects (2016A020217016).
Weitere Informationen

Publikationsverlauf

07. September 2018

18. November 2018

Publikationsdatum:
07. Januar 2019 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Background Inflammation plays an important role in thrombus formation, and Sirtuin 1 (SIRT1) negatively regulates inflammation via deacetylating nuclear factor-kappa B. However, the relationship between SIRT1-regulated inflammation and deep vein thrombosis (DVT) is still unknown.

Objective The aim of this study was to investigate whether SIRT1 plays a critical role in inferior vena cava (IVC) stenosis-induced DVT.

Materials and Methods Thrombus weight and histopathologic analysis of IVC were evaluated at different time points after IVC stenosis in rats. Serum levels of inflammatory cytokines and protein expressions of SIRT1, acetylated p65 (Ace-p65), phosphorylated p65 (p-p65) and tissue factor (TF) in thrombosed IVC were assessed. Besides, the effects of resveratrol (RES, a SIRT1 agonist) and EX527 (a selective SIRT1 inhibitor) on DVT were evaluated.

Results Thrombus weight was increased from 1 to 3 days after IVC stenosis, and then was decreased afterwards. Leukocytes infiltration appeared and serum levels of cytokines were significantly increased in rats of IVC stenosis. SIRT1 protein expression was significantly down-regulated at 1 hour and 1 day after stenosis, while p-p65, Ace-p65 and TF protein expressions appeared a contrary trend. RES reduced thrombus weight, leukocytes infiltration, levels of tumour necrosis factor-α and interleukin-1β and protein expressions of Ace-p65 and TF as well. Moreover, RES significantly increased the protein and messenger ribonucleic acid expressions of SIRT1, while EX527 abolished the protective effects of RES.

Conclusion SIRT1 activation attenuated IVC stenosis-induced DVT via anti-inflammation in rats. Therefore, SIRT1 may be a potential therapeutic target that could ameliorate DVT.

Keywords

deep vein thrombosis - SIRT1 - inflammation - resveratrol - EX527

Authors' Contributions

Baoqin Lin designed the research studies. Xaolan Yao performed the experiment and wrote the manuscript. Wenpei Chen, Jin Liu, Han Liu, Janis Y. Zhan, Shixia Guan, Ziqi Lu, Ping Tang and Peng Li analysed and interpreted data. All authors revised the manuscript and approved the final version.


Supplementary Material

 

  • References

  • 1 Di Minno MN, Ambrosino P, Ambrosini F, Tremoli E, Di Minno G, Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost 2016; 14 (05) 964-972
    CrossrefPubMedGoogle Scholar
  • 2 Bawa H, Weick JW, Dirschl DR, Luu HH. Trends in deep vein thrombosis prophylaxis and deep vein thrombosis rates after total hip and knee arthroplasty. J Am Acad Orthop Surg 2018; 26 (19) 698-705
    CrossrefPubMedGoogle Scholar
  • 3 Glynn RJ, Ridker PM. Inflammation, venous thromboembolism, and what we can do about it. Eur Heart J 2018; 39 (39) 3615-3617
    CrossrefPubMedGoogle Scholar
  • 4 Wang LM, Duan QL, Yang F. , et al. Activation of circulated immune cells and inflammatory immune adherence are involved in the whole process of acute venous thrombosis. Int J Clin Exp Med 2014; 7 (03) 566-572
    PubMedGoogle Scholar
  • 5 Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol 2016; 99: 272-285
    CrossrefPubMedGoogle Scholar
  • 6 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13 (01) 34-45
    CrossrefPubMedGoogle Scholar
  • 7 Schulz C, Engelmann B, Massberg S. Crossroads of coagulation and innate immunity: the case of deep vein thrombosis. J Thromb Haemost 2013; 11 (Suppl. 01) 233-241
    CrossrefPubMedGoogle Scholar
  • 8 Zhang Z, Hu L, Chen W, Zhou C, Gui G, Lin B. Danhong huayu koufuye prevents deep vein thrombosis through anti-inflammation in rats. J Surg Res 2016; 201 (02) 340-347
    CrossrefPubMedGoogle Scholar
  • 9 Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood 2016; 128 (06) 753-762
    CrossrefPubMedGoogle Scholar
  • 10 Saha P, Humphries J, Modarai B. , et al. Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol 2011; 31 (03) 506-512
    CrossrefPubMedGoogle Scholar
  • 11 Pikarsky E, Porat RM, Stein I. , et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431 (7007): 461-466
    PubMedGoogle Scholar
  • 12 Malaponte G, Signorelli SS, Bevelacqua V. , et al. Increased levels of NF-κB-dependent markers in cancer-associated deep venous thrombosis. PLoS One 2015; 10 (07) e0132496
    CrossrefPubMedGoogle Scholar
  • 13 Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404 (01) 1-13
    CrossrefPubMedGoogle Scholar
  • 14 Haigis MC, Guarente LP. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006; 20 (21) 2913-2921
    CrossrefPubMedGoogle Scholar
  • 15 Liu TF, Vachharajani VT, Yoza BK, McCall CE. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem 2012; 287 (31) 25758-25769
    CrossrefPubMedGoogle Scholar
  • 16 Yoshizaki T, Milne JC, Imamura T. , et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009; 29 (05) 1363-1374
    CrossrefPubMedGoogle Scholar
  • 17 Breitenstein A, Stein S, Holy EW. , et al. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovasc Res 2011; 89 (02) 464-472
    CrossrefPubMedGoogle Scholar
  • 18 Hayashi H, Cherpokova D, Martinod K. , et al. Sirt3 deficiency does not affect venous thrombosis or NETosis despite mild elevation of intracellular ROS in platelets and neutrophils in mice. PLoS One 2017; 12 (12) e0188341
    CrossrefPubMedGoogle Scholar
  • 19 de Lange P, Cioffi F, Senese R. , et al. Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats. Diabetes 2011; 60 (11) 2730-2739
    Google Scholar
  • 20 Zhang H, Yan H, Zhou X. , et al. The protective effects of Resveratrol against radiation-induced intestinal injury. BMC Complement Altern Med 2017; 17 (01) 410
    CrossrefPubMedGoogle Scholar
  • 21 Nosaka M, Ishida Y, Kimura A, Kondo T. Time-dependent appearance of intrathrombus neutrophils and macrophages in a stasis-induced deep vein thrombosis model and its application to thrombus age determination. Int J Legal Med 2009; 123 (03) 235-240
    CrossrefPubMedGoogle Scholar
  • 22 Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003; 1 (07) 1343-1348
    CrossrefPubMedGoogle Scholar
  • 23 Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15 (07) 254-259
    CrossrefPubMedGoogle Scholar
  • 24 Scaldaferri F, Sans M, Vetrano S. , et al. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest 2007; 117 (07) 1951-1960
    CrossrefPubMedGoogle Scholar
  • 25 Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96 (12) 1233-1239
    CrossrefPubMedGoogle Scholar
  • 26 Nishimura S, Manabe I, Nagasaki M. , et al. In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling. Blood 2012; 119 (08) e45-e56
    CrossrefPubMedGoogle Scholar
  • 27 Chu AJ. Tissue factor mediates inflammation. Arch Biochem Biophys 2005; 440 (02) 123-132
    CrossrefPubMedGoogle Scholar
  • 28 Gillum MP, Kotas ME, Erion DM. , et al. SirT1 regulates adipose tissue inflammation. Diabetes 2011; 60 (12) 3235-3245
    CrossrefPubMedGoogle Scholar
  • 29 Cao L, Liu C, Wang F, Wang H. SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway. Braz J Med Biol Res 2013; 46 (08) 659-669
    PubMedGoogle Scholar
  • 30 Li J, Li L, Wang S. , et al. Resveratrol alleviates inflammatory responses and oxidative stress in rat kidney ischemia-reperfusion injury and H2O2-induced NRK-52E cells via the Nrf2/TLR4/NF-κB pathway. Cell Physiol Biochem 2018; 45 (04) 1677-1689
    CrossrefPubMedGoogle Scholar
  • 31 Xu M, Cheng Z, Ding Z, Wang Y, Guo Q, Huang C. Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in spinal cord and attenuates neuropathic pain following sciatic nerve injury. Mol Pain 2018; 14: 1744806918767549
    CrossrefPubMedGoogle Scholar
  • 32 Zhao H, Chen S, Gao K. , et al. Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway. Neuroscience 2017; 348: 241-251
    CrossrefPubMedGoogle Scholar
  • 33 Timmers S, Auwerx J, Schrauwen P. The journey of resveratrol from yeast to human. Aging (Albany NY) 2012; 4 (03) 146-158
    CrossrefPubMedGoogle Scholar
  • 34 Sin TK, Yung BY, Yip SP. , et al. SIRT1-dependent myoprotective effects of resveratrol on muscle injury induced by compression. Front Physiol 2015; 6: 293
    PubMedGoogle Scholar
  • 35 Tong Z, Xie Y, He M. , et al. VDAC1 deacetylation is involved in the protective effects of resveratrol against mitochondria-mediated apoptosis in cardiomyocytes subjected to anoxia/reoxygenation injury. Biomed Pharmacother 2017; 95: 77-83
    CrossrefPubMedGoogle Scholar
  • 36 Xu S, Gao Y, Zhang Q. , et al. SIRT1/3 activated by resveratrol attenuates acute kidney injury in a septic rat model. Oxid Med Cell Longev 2016; 2016: 7296092
    PubMedGoogle Scholar
  • 37 Liu J, Han W, Chen L, Tang K. Mechanism of osteogenic and adipogenic differentiation of tendon stem cells induced by sirtuin 1. Mol Med Rep 2016; 14 (02) 1643-1648
    CrossrefPubMedGoogle Scholar
  • 38 Guo H, Chen Y, Liao L, Wu W. Resveratrol protects HUVECs from oxidized-LDL induced oxidative damage by autophagy upregulation via the AMPK/SIRT1 pathway. Cardiovasc Drugs Ther 2013; 27 (03) 189-198
    CrossrefPubMedGoogle Scholar